Existing investors top off Cylene's C round

Cylene Pharmaceuticals Inc. (San Diego, Calif.) raised $12 million in an extension of a series C round, bringing the total raised in the round to $56 million. Existing investors Sanderling Ventures; HBM BioVentures; Novartis BioVenture Fund; BioVentures Investors; Lilly Ventures; Mitsui; and Morningside Venture Investments participated. ...